Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen

Roberta Ferraldeschi; Sacha J. Howell; Alastair M. Thompson; William G. Newman

doi:10.1200/JCO.2010.30.1887

Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen

Roberta Ferraldeschi, Sacha J. Howell, Alastair M. Thompson, William G. Newman

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E584-E585
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	28
Issue number	29
DOIs	https://doi.org/10.1200/JCO.2010.30.1887
Publication status	Published - 2010

Keywords

BREAST-CANCER-TREATMENT
ANTIDEPRESSANT USE
RECURRENCE RISK
METABOLISM
GENOTYPE
WOMEN

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2010.30.1887

Cite this

@article{5a382983223a44fbb02dc8d58a5c159f,

title = "Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen",

keywords = "BREAST-CANCER-TREATMENT, ANTIDEPRESSANT USE, RECURRENCE RISK, METABOLISM, GENOTYPE, WOMEN",

author = "Roberta Ferraldeschi and Howell, {Sacha J.} and Thompson, {Alastair M.} and Newman, {William G.}",

year = "2010",

doi = "10.1200/JCO.2010.30.1887",

language = "English",

volume = "28",

pages = "E584--E585",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "29",

}

TY - JOUR

T1 - Avoidance of CYP2D6 Inhibitors in Patients Receiving Tamoxifen

AU - Ferraldeschi, Roberta

AU - Howell, Sacha J.

AU - Thompson, Alastair M.

AU - Newman, William G.

PY - 2010

Y1 - 2010

KW - BREAST-CANCER-TREATMENT

KW - ANTIDEPRESSANT USE

KW - RECURRENCE RISK

KW - METABOLISM

KW - GENOTYPE

KW - WOMEN

U2 - 10.1200/JCO.2010.30.1887

DO - 10.1200/JCO.2010.30.1887

M3 - Letter

C2 - 20823421

SN - 0732-183X

VL - 28

SP - E584-E585

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 29

ER -